Cell cycle progression is tightly regulated by cyclin-dependent kinases (CDKs). The ankyrin-repeat protein p19
. This dissociates the CDK6-p19
INK4d inhibitory complex and, thereby, activates CDK6. CDK6 triggers entry into S-phase, whereas p19
INK4d is ubiquitinated and degraded. Our findings reveal how signalingdependent p19
INK4d unfolding contributes to the irreversibility of G1/S transition.
cell cycle | p19INK4d | protein unfolding | protein phosphorylation | NMR spectroscopy C ell cycle progression from the G1 to S-phase is tightly coupled to the transcriptional control of genes involved in growth and DNA replication (1) . In mammalian cells, G1/S transition is primarily mediated by the E2F family of transcription factors (2) . E2F proteins E2F1 to E2F8 form heterodimeric E2 promoter-binding-protein-dimerization partner complexes (E2F-DP) with members of the distantly related DP family of proteins (3) . Most E2F proteins harbor dedicated protein binding domains that interact with E2F targets upon phosphorylation (4) to form inactive, ternary E2F-DP complexes (5) that stall cells in G1. Such cascades also prevent cells from replicating damaged DNA (6) . To successfully enter S-phase, cyclin-dependent protein kinase (CDK)-cyclin complexes (7) hyperphosphorylate (5) and disrupt the E2F-DP assemblies (8) and, in turn, activate E2F-dependent gene expression necessary for G1/S transition ( Fig. 1) . Therefore, CDKs, such as CDK4/6, play major roles in cell cycle progression. CDK4/6 are controlled via their regulatory subunits including D-type cyclins and specific cyclin-dependent kinase inhibitors (CKIs), of which two families are known. Specifically, CKIs belonging to the INK4 family of proteins (p16 INK4a , p15 INK4b , p18 INK4c , and p19 INK4d ) ( Fig. 1 ) inhibit CDK4 and CDK6, whereas CKIs of the Cip/Kip family (p21 Cip1,WAF-1 , p27 Kip1 , and p57 Kip2 ) act on CDK2 and other CDKs (7, 9, 10) . p19
INK4d has distinct features compared with the other four members of the INK4 family; mRNA and protein levels accumulate during S-phase and sharply decline at the onset of G2. High amounts of p19
INK4d inhibit CDK4/6-cyclin D activity and determine the length of G1, also ensuring the directionality of cell cycle progression (7) . In exponentially growing U2OS cells, p19
INK4d is found to be phosphorylated at two sites, tentatively assigned to Ser66 and Ser76 (11) . Additional regulation by ubiquitination appears to be restricted to p19
INK4d , thought to involve Lys62 and depend on CDK4 binding. Given that cellular concentrations of p19
INK4d oscillate during the cell cycle, it has been proposed that regulated modification events at these sites determine the fate of intracellular p19 INK4d (11) . In-cell NMR allows the study of proteins and their posttranslational modifications in cellular environments (12) (13) (14) . Alternatively, purified isotope-labeled proteins of interest may be added directly to unlabeled, native cell lysates to study how endogenous cellular proteins, such as kinases, phosphatases, or proteases act on them (15, 16) . Here, we adopted the latter approach to gain mechanistic insights into the phosphorylation behavior of full-length human p19
INK4d and to interrogate structural and functional consequences of such modifications. We show that p19
INK4d Ser66 and Ser76 are phosphorylated by cellular p38 and CDK1 in a strictly stepwise and cell cycledependent manner. In response, p19
INK4d locally unfolds and dissociates from CDK6, which triggers Lys62 ubiquitination and, ultimately, leads to cellular p19
INK4d degradation. Hence, we demonstrate how the combined use of cell biology and NMR spectroscopy enables insights into the molecular mechanisms that regulate p19
INK4d activity during cell cycle progression.
Results p19
INK4d Phosphorylation at Ser66. p19
INK4d is an ankyrin-repeat (AR) protein that harbors five evenly spaced helix-turn-helix motifs: AR1 amino acids 9-29, AR2 amino acids 54-62, AR3 amino acids 77-95, AR4 amino acids 110-128, and AR5 amino acids 142-159 (Fig. 1 ). AR1 and AR2 mediate inhibitory CDK4/6 binding (17) . Phosphorylation of Ser66 and Ser76 within the linker region Significance Cell cycle progression is tightly controlled in healthy organisms and often perturbed in human diseases, including, most prominently, many forms of cancers. Cyclin-dependent protein kinases and their inhibitors, such as p19 INK4d , regulate the different stages of the cell cycle. Here, we demonstrate how sequential phosphorylation of p19
INK4d at two sites first destabilizes and then unfolds the N-terminal half of the protein, which dissociates its cyclin-dependent protein kinaseinhibitory complex and primes p19
INK4d for cellular degradation. Our results define a structural mechanism by which phosphorylation-induced protein unfolding controls a key step in cell cycle progression.
connecting AR2 and AR3 is thought to regulate p19
INK4d activity, but kinases that modify these sites have not been identified. We expressed and purified full-length human p19
INK4d (residues 1-166) from Escherichia coli and added the recombinant protein to lysates that we prepared from various cultured cell lines (e.g., HeLa, U2OS, HEK-293 grown asynchronously, and from Drosophila melanogaster embryos). 32 P-incorporation and autoradiography exposure confirmed phosphorylation by endogenous enzymes (Fig. S1A) Fig. S1 B-D). Although residues close to Ser66 also displayed slight alterations in their cross-peak positions (red in Fig. 2A , Lower), other p19
INK4d serines, including Ser76, were unaffected. These results indicated that all five ARs remained structurally intact upon Ser66 phosphorylation. In the 1D 31 P NMR spectrum, phospho-Ser66 gave rise to a characteristic new resonance at −1 ppm, which was clearly offset from the bulk phosphate-buffer signal at 2 ppm ( Fig. 2A, Inset) . We confirmed the presence of a single protein-phosphate moiety by MALDI-TOF mass spectrometry ( Fig. S2 A and B) . To verify the identity of Ser66 as the primary phosphorylation site, we repeated these experiments with alaninesubstituted, mutant p19
INK4d (e.g., S66A). We detected neither 32 P incorporation nor the appearance of the 31 P-NMR resonance signal at −1 ppm. These data confirmed that endogenous kinases in lysates prepared from asynchronously growing mammalian cells, or from Drosophila embryos, phosphorylated p19
INK4d at Ser66.
Stepwise Phosphorylation of Ser66 and Ser76 Induces Local
Unfolding. Having preformed the previous set of experiments in lysates of asynchronously growing cells, we were unable to delineate cell cycle-specific contributions to the observed phosphorylation reaction. To our surprise, we also did not detect endogenous p19 INK4d in our lysates (Fig. S2C, lane 1) . Because the G1/S transition is tightly controlled by CDK4/6 and INK4, we speculated that the kinase targeting p19
INK4d might only be active in a fraction of our collected cells, specifically those in S-phase. To test this hypothesis, we subjected HeLa cells to a double thymidine block to arrest them in S-phase (19) . We detected abundant amounts of endogenous p19
INK4d in these lysates (Fig. S2C, lane 2) . Upon thymidine removal and G2 release, p19
INK4d levels dropped below the detection limit within 6 h (Fig. S2C, lanes 3 and 4) . These findings reaffirmed earlier studies with proliferating cells (20) that INK4d structure. The macroscopic helix dipole moments of helices 4 and 6 are depicted by black arrows in A. Mapping of cross-peak on the p19
INK4d structure in A and B: red, missing cross-peak; blue, no change; and gray, slight chemical shift or cannot say. Insets show the 1D 31 P spectra identifying (A) one (−1 ppm), (B) two (−1 ppm and 4 ppm), and (C) no protein-bound phosphate. The sharp signal at 2 ppm originates from the phosphate buffer (asterisk).
cellular p19
INK4d concentrations were highest in S-phase and virtually absent in G1, thus consolidating the notion of a genuine oscillatory behavior.
Next, we sought to investigate p19 INK4d modifications in lysates of S-phase-arrested cells. 32 P incorporation and autoradiography exposure confirmed p19
INK4d phosphorylation (Fig. S2D) . The 1D 31 P NMR experiments revealed the previously observed phosphoresonance at −1 ppm, plus a new signal at 4 ppm, suggesting the presence of a second modified residue under these conditions (Fig. 2B, Inset) . MALDI-TOF mass spectrometry indeed confirmed phosphorylation of p19
INK4d at two sites ( Fig. S2 A and E) . To also interrogate possible structural changes of doubly phosphorylated p19
INK4d
, we recorded 2D 1 H- 15 N HSQC spectra on exogenously added, isotope-labeled protein in lysates of S-phasearrested HeLa cells (Fig. 2B) . Surprisingly, we found all p19
INK4d residues of AR1, AR2, and AR3 at new peak positions, narrowly dispersed around 8 ppm along the proton dimension (Fig. 2B and  Fig. S2F ). Such NMR features are highly characteristic of unfolded protein states. In contrast, residues within AR4 and AR5 exhibited no chemical-shift changes, indicating that these ARs remained folded upon dual p19
INK4d phosphorylation. Having established that Ser66 likely constituted one of the modified p19
INK4d residues, we set out to identify the second phosphorylation site. To this end, we mutated Ser76 to alanine (S76A) and repeated the S-phase lysate NMR experiment. The 2D 1 H- 15 N HSQC spectra showed that AR1-3 residues, along with those of AR4 and AR5, maintained their original cross-peak positions, hinting toward the structural preservation of all ARs (Fig. 3F and Fig. S2G ). Moreover, we clearly detected Ser66 phosphorylation in S76A p19
INK4d , suggesting that primary phosphorylation of this site was not affected in the mutant background. Taken together, these results led us to conclude that Ser76 constituted the second p19
INK4d modification site in S-phase-arrested cell extracts, that phosphorylation of Ser66 was pursued independent of Ser76 modification, and that double phosphorylation of Ser66 and Ser76 resulted in local unfolding of ankyrin repeats AR1-3.
To confirm that the observed conformational changes were indeed due to phosphorylation, and to test whether local AR1-3 unfolding was reversible, we added a nonspecific alkaline phosphatase to Ser66-, Ser76-modified p19 INK4d . Dephosphorylation resulted in the disappearance of phosphoprotein resonances in 1D 31 P NMR spectra (Fig. 2C , Inset) and recovered all p19
INK4d resonances at their original crosspeak positions in 2D 1 H-15 N HSQC spectra (Figs. 2C and  3C) . These experiments confirmed that: (i) double phosphorylation caused unfolding and (ii) that unfolding was fully reversible. They further excluded contributions by other posttranslational protein modifications, which may have remained undetected in lysate NMR experiments.
p38 and CDK1 Phosphorylate Ser66 and Ser76, Respectively. We observed Ser66 phosphorylation in lysates of asynchronously growing cells, as well as in lysates of cells arrested in S-phase, which suggested that this modification is mediated by a kinase that is not stringently cell cycle-regulated. In contrast, we only detected Ser76 phosphorylation in S-phase lysates, arguing for an enzyme with cell cycle-specific activity. To identify the respective kinases that modified Ser66 and Ser76 of p19 INK4d , we treated S-phase lysates with different kinase inhibitors. Compounds targeting CDK1, CDK4, or protein kinase A (PKA) did not affect Ser66 phosphorylation (Fig. S3 A-C) . In contrast, selective inhibition of the constitutively expressed kinase p38 (21-23) abolished its modification (Fig. 3E and Fig. S3D ). We further confirmed p38 selectivity and specificity in reconstituted kinase reactions with isolated wild-type and S66A-mutant p19
INK4d (Fig.   S3E ). Furthermore, in an autoradiography experiment, p19
S66A remained silent (Fig. S3E ). p38 is a stress-activated MAP kinase protein family and we found Ser66 to get phosphorylated under various conditions not related to the cell cycle. Therefore, p38 may not be the only kinase that phosphorylates Ser66.
Following a similar approach, we found that different CDK1 inhibitors abolished Ser76 phosphorylation, whereas modification of Ser66 was unperturbed (Fig. 3D and Fig. S4 A  and B) . In earlier studies, CDK2 was found to phosphorylate Ser76 in response to DNA damage (24) . The herein used CDK1 inhibitor IV inhibits CDK2 to some extent at elevated concentrations (25) , but the specific CDK1 inhibitor III does not (26) . Sole inhibition of CDK2 by inhibitor I (Fig. S4C) and, as expected, treating S-phase cell lysates with CDK4 or PKA inhibitors, showed no effects (Fig. S4 D and E) . Together, these results suggested that, predominantly, CDK1 mediated Ser76 phosphorylation. Accordingly, we found that CDK1-cyclin B reconstituted kinase reactions modified wild-type but not S76A-mutant p19
INK4d (Fig. S5A) . CDK1, in complex with cyclins A, B, D, or E, functions as a key cell cycle regulator (27) (28) (29) and p19
INK4d exhibits several features of a canonical CDK1 substrate (30) . It harbors multiple serine or threonine residues followed by a proline (e.g., minimal Ser/Thr-Pro motifs, including Ser66, Ser76, and Thr141), and it contains a classic Arg-X-Leu CDK docking site, which all remain accessible when p19
INK4d is bound to CDK4/ 6 ( Fig. 1, Left) . To further substantiate the role of CDK1 in Ser76 phosphorylation, we arrested HeLa cells in M-phase, in which CDK1/cyclin B activity is the highest, and prepared lysates to which we added 15 N isotope-labeled p19
. The 2D NMR experiments revealed local unfolding of AR1-3, manifested by spectral characteristic that were indistinguishable from results in S-phase-arrested cell extracts (Fig. S5 B-D) . Indeed, NMR spectra of isotope-labeled p19
INK4d in reconstituted mixtures of isolated p38α and CDK1/cyclin B showed identical features (Fig.  S6) . In summary, our combined results strongly suggested that p38 and CDK1 constitute the cellular kinases that phosphorylate Ser66 and Ser76 of p19 phosphorylation, we set out to gain mechanistic insights into the Ser66 and Ser76 modification process. Specifically, we asked whether Ser76 phosphorylation required Ser66 modification as a preceding event. We had found that phosphorylation of Ser76 did not occur in the S66A-mutant background (Fig. 3G ) or upon p38 inhibition in S-phase cell lysates (Fig. 3H and Fig. S7 A and B) , thus raising the possibility that Ser66, Ser76 phosphorylation may constitute a hierarchical, sequential process. Protein phosphorylation sites are generally located in accessible loop and linker regions of folded substrates (30) . In p19
, Ser66 is surface-exposed, whereas Ser76 is part of the helical AR3 motif and rather occluded (Fig. 1, Left) . As mentioned above, Ser66 phosphorylation led to several NMR chemical-shift changes of residues in its vicinity (Fig. 2A) . We hypothesized that these reported on local destabilization of p19
INK4d residues surrounding the modification site, probably via repulsive electrostatic interactions of the Ser66 phosphate moiety and the negative charge of the net dipole moments at the C-terminal ends of helices 4 and 6 in AR2 and AR3, respectively ( Fig. 2A , and arrows on the corresponding p19
INK4d structure). In agreement with this model, residues in these helices displayed the largest chemical-shift changes upon Ser66 phosphorylation ( Fig. 2A) . To assess the degree of helix destabilization in response to Ser66 modification, we performed proton-deuteron (H-D) backbone amide exchange experiments by NMR. AR3 and AR4 residues in wild-type p19
INK4d exhibited protection factors above 10 5 ( Fig. S7C ) (31) , which reduced significantly upon phosphorylation (red in Fig. S7 D-F) . Surprisingly, even though p19
INK4d residues within AR1, -4, and -5 did not show chemicalshift changes when Ser66 was phosphorylated, we measured greater solvent-amide proton exchange at these "remote" structural elements, synonymous with lower thermodynamic stabilities in the presence of modified Ser66. Based on these findings, we hypothesized that extended structural destabilization may provide the necessary access for Ser76 phosphorylation by CDK1 (Fig. 1) . Local unfolding of AR1-3 may then occur due to additional breaking of hydrogen bonds, such as the one between Ser76 O γ and V69 O′, for example.
Phosphorylation Dissociates the CDK6-p19
INK4d Complex. How does p19
INK4d phosphorylation correlate with its function as a cell cycle regulator? The crystal structure of the inhibitory CDK6-p19
INK4d complex reveals its molecular architecture (17) but it remained unclear how the assembly dissociates and whether p19
INK4d modifications affected this process. Therefore, we examined p19
INK4d phosphorylation in context of the assembled CDK6-p19
INK4d complex. In vitro pull-down assays showed that unmodified p19
INK4d specifically bound to GST-CDK6 (31), whereas doubly phosphorylated p19
INK4d did not (Fig. 4A) , likely because a folded AR1-2 interface is required for CDK6 binding (Fig. 1, Left) . In a second experiment, we followed 15 N-p19 INK4d binding to unlabeled CDK6 by NMR spectroscopy. As we expected from the crystal structure of the complex, p19
INK4d AR1 and AR2 residues exhibited pronounced chemical-shift changes upon addition of CDK6 (Fig. 4  B and C) . No chemical-shift changes were observed when we added CDK6 to doubly phosphorylated p19 INK4d , which confirmed the absence of binding and recapitulated our pull-down results. When we treated assembled CDK6- 15 
N-p19
INK4d with Sphase-arrested cell lysates, 2D NMR spectra revealed local unfolding of AR1-3, similar to the isolated protein upon Ser66 and Ser76 phosphorylation (Fig. 4D, Middle) . Indeed, 1D 31 P NMR spectra and radioisotope incorporation experiments confirmed the presence of both modifications (Fig. 4D, Bottom) . We concluded that p19
INK4d double phosphorylation and subsequent local unfolding dissociated the p19 INK4d -CDK6 complex.
Ubiquitination Requires p19
INK4d Unfolding. Many proteins turn into E3 ubiquitin ligase substrates upon phosphorylation, causing them to be degraded by the ATP-dependent ubiquitin/proteasome system (32, 33) . Here, we showed that p19
INK4d phosphorylation at Ser66 and Ser76 caused local unfolding of AR1-3, which, in turn, released the protein from CDK6. What was the 
